Delivery Order SPE2DB24D2205-SPE2DB26FDSWF
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Mounjaro 5 mg/0.5 mL pen injectors with a ceiling value of $58,321.91 under firm fixed pricing. This is a non-set-aside competitively awarded delivery order with an ultimate completion date of September 29, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Mounjaro 5 mg/0.5 ml pen injectors with a ceiling value of $4,871.43. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively determined. The delivery location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of April 25, 2025. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Mounjaro 10 mg/0.5 mL pen injectors with a ceiling value of $1,285.13. This firm fixed-price delivery order, which is not set-aside designated, represents a competitive procurement under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,182.67 on August 8, 2025, for the supply of Mounjaro 5 mg/0.5 mL pen injectors with an ultimate completion date of August 11, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 2.5 mg/0.5 mL pen injectors on October 14, 2025, with an ultimate completion date of October 15, 2025. The contract is valued at $1,632.54 and utilizes firm fixed price pricing with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's Corporate Office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Mounjaro 15 mg/0.5 mL pen injectors with a ceiling value of $4,897.62. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 26, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger indefinite delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Mounjaro 5 mg/0.5 ml pen injectors with a ceiling value of $132,811.30. The contract is a firm fixed-price delivery order with an ultimate completion date of September 18, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. No set-aside designation was used in this award, indicating it was competitively awarded. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Mounjaro 7.5 mg/0.5 ml pen injectors with a contract ceiling value of $2,879.11. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 7, 2025. This award is a...
- The Defense Logistics Agency awarded a $4,353.44 firm fixed-price delivery order to AmerisourceBergen Drug Corp on March 14, 2025, for the supply of Mounjaro 10 mg/0.5 ml pen injectors (0.5 ml). This is a non-set-aside competitive award with an ultimate completion date of March 17, 2025, and represents performance by AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 7, 2025, for the supply of Mounjaro 10 mg/0.5 ml pen injectors with a ceiling value of $23,045.51. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The place of performance is listed as Conshohocken, Pennsylvania, which is also the location of AmerisourceBergen Drug Corp's corporate headquarters. This delivery order is a...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB26FDSWFDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of Mounjaro 2.5 mg/0.5 mL pen injectors with a ceiling value of $5,856.76. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of October 30, 2025. The order will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime vendor agreement extending through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, has established itself as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to meet complex pharmaceutical supply requirements across multiple therapeutic domains, including diabetes medications, neurological treatments, and specialty medical supplies. This delivery order for Mounjaro, a diabetes management medication, reflects the company's ongoing role in supporting the Defense Health Agency and other federal healthcare systems through its flexible and comprehensive contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.9k | 10/29/25 |